[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-563258-105":53,"doc-detail-563258-en":120},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":113,"head_meta":115,"extra_data":117,"updated_unix":119},105,"en","advanced-pain-management-in-dogs-and-cats-lecture","Advanced Pain Management in Dogs and Cats - Lecture","","Advanced pain management guidance for dogs and cats, emphasizing that pain control goes beyond NSAIDs and opioids while still using them appropriately. The lecture covers NSAID and opioid staples by species, then outlines steroid anti-inflammatory use and the goal of opioid-sparing strategies. It details pharmaceuticals including gabapentin with low-and-slow dosing, side effects, and patient-dependent considerations. It also explains NMDA receptor antagonists, focusing on amantadine and ketamine dosing, timing, administration routes, and common adverse effects.",{"@graph":63,"@context":112},[64,80,95],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/advanced-pain-management-in-dogs-and-cats-lecture/563258/",4,{"url":78,"name":59,"@type":81,"author":82,"headline":59,"publisher":85,"fileFormat":88,"inLanguage":57,"description":61,"dateModified":89,"datePublished":89,"encodingFormat":88,"isAccessibleForFree":90,"interactionStatistic":91},"DigitalDocument",{"name":83,"@type":84},"sagouaw","Person",{"url":68,"name":86,"@type":87},"DocShare","Organization","application/pdf","2026-10-12",true,{"@type":92,"interactionType":93,"userInteractionCount":4},"InteractionCounter",{"@type":94},"ViewAction",{"@type":96,"mainEntity":97},"FAQPage",[98,104,108],{"name":99,"@type":100,"acceptedAnswer":101},"How does the lecture define effective pain management beyond NSAIDs and opioids?","Question",{"text":102,"@type":103},"It frames pain management as broader than just NSAIDs and opioids, while still acknowledging their continued importance. The approach supports multimodal strategies to improve patient comfort and treatment outcomes.","Answer",{"name":105,"@type":100,"acceptedAnswer":106},"What dosing strategy is recommended for gabapentin, and what side effects should be monitored?",{"text":107,"@type":103},"Gabapentin is recommended with low and slow dosing, starting at 3–5 mg/kg per dose once daily at night/bedtime and increasing after 3–7 days based on patient response. Side effects include sedation and ataxia.",{"name":109,"@type":100,"acceptedAnswer":110},"When are NMDA receptor antagonists like amantadine and ketamine used, and how are they administered?",{"text":111,"@type":103},"Amantadine is best for chronic pain and is given orally, often requiring 2–3 weeks to see improvement. Ketamine is administered SQ with a subanesthetic dose, given between the shoulder blades, and is described as useful for conditions such as osteosarcoma patients, chronic IVDD, and end-stage OA.","https://schema.org",{"og:url":78,"og:type":114,"og:title":59,"og:site_name":86,"og:description":61},"article",{"robots":116,"canonical":78},"index,follow",{"doc_id":118,"site_id":56},563258,1791823932,{"code":4,"msg":5,"data":121},{"doc_id":118,"user_id":122,"nickname":83,"user_avatar":123,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":124,"file_id":125,"file_url":126,"file_type":127,"file_size":128,"view_count":4,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":129,"language":130,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":131,"faqs":132,"seo_title":133,"seo_description":61,"update_tm":119,"read_time":134},3985747862151,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Advanced Pain Management  \n in Dogs and Cats   \nJULIA SPADE, DVM, CHPV, CVMA  \nDISCLAIMER  \nI have no conflict of interest in this presentation.  \nSome of my recommendations include off-label usage of medications. These are used in the best interest of our  \npatients and many times anecdotal in nature.   \nPAIN MANAGEMENT IS MORE THAN NSAIDS AND OPIOIDS...  \nBUT WE STILL NEED THEM!  \nNSAIDs:  \n-Staple for arthritis management  \n-Dogs: carprofen, meloxicam and grapiprant  \n-Cats: low dose meloxicam, robenacoxib  \n-Piroxicam and meloxicam:  \nAnti-neoplastic properties  \nOpioids:  \n-Buprenorphine (most often used opioid in our practice for pain management)  \n-Still useful and necessary  \n-Want to strive for opioid sparing  \nSteroids:  \n-Prednisone, prednisolone, dexamethasone  \n-Anti-inflammatory of choice:  \nSome animals with co-morbidities  \nPharmaceuticals  \nGabapentin  \n❖ Low and slow dosing  \n❖ Recommended dosing if naïve to the medication:  \n❖ Start at 3-5 mg/kg per dose  \n❖ Start with dosing once daily at night/bedtime  \n❖ Increase to twice daily after 3-7 days depending on patient and pain level  \n❖ Side effects: sedation, ataxia  \n❖ Clients can be hesitant to try this medication again if their dog was prescribed a high dose and experienced sedation and/or ataxia  \n❖ Patient dependent  \n❖ Wide safety margin  \nNMDA Receptor Antagonists  \n| When to use them? |  |\n| --- | --- |\n\nTwo drugs:  \nAmantadine  \n❖ Oral administration  \n❖ Best for chronic pain; would not choose for early OA  \n❖ Third in line for chronic arthritis after NSAID and gabapentin May take 2-3 weeks to see a difference, but some respond faster (even within a few days)  \n❖ Can be used in conjunction with ketamine  \n❖ Starting dose: 3-5 mg/kg IN THE MORNING; then q12h after 3-7 days of morning dosing  \n❖ For severe pain cases, consider q8h  \n❖ Side effects: Diarrhea, agitation  \nKetamine  \n❖ SQ administration; dogs and cats  \n❖ Subanesthetic dose; In addition to oral medications  \n❖ Can be used in conjunction with amantadine  \n❖ Dose recommendation: 0.25-0.5 mg/kg SQ every 1 to 4 weeks  \n❖  Side effects: Sedation, dissociation (uncommon at this dose)  \n❖ GIVE BETWEEN THE SHOULDER BLADES  \n❖ Excellent for use in osteosarcoma patients, chronic IVDD, and end-stage OA  \n❖ Anecdotal!","cbCaiuCaJNydnVSu","https://ap.wps.com/l/cbCaiuCaJNydnVSu","pdf",4074364,28,"English","# NSAIDs and Opioids\n## NSAIDs by species\n## Opioid goals and examples\n# Steroids\n# Pharmaceuticals\n## Gabapentin dosing and side effects\n## NMDA receptor antagonists\n### Amantadine\n### Ketamine","[{\"question\":\"How does the lecture define effective pain management beyond NSAIDs and opioids?\",\"answer\":\"It frames pain management as broader than just NSAIDs and opioids, while still acknowledging their continued importance. The approach supports multimodal strategies to improve patient comfort and treatment outcomes.\"},{\"question\":\"What dosing strategy is recommended for gabapentin, and what side effects should be monitored?\",\"answer\":\"Gabapentin is recommended with low and slow dosing, starting at 3–5 mg/kg per dose once daily at night/bedtime and increasing after 3–7 days based on patient response. Side effects include sedation and ataxia.\"},{\"question\":\"When are NMDA receptor antagonists like amantadine and ketamine used, and how are they administered?\",\"answer\":\"Amantadine is best for chronic pain and is given orally, often requiring 2–3 weeks to see improvement. Ketamine is administered SQ with a subanesthetic dose, given between the shoulder blades, and is described as useful for conditions such as osteosarcoma patients, chronic IVDD, and end-stage OA.\"}]","Advanced Pain Management in Dogs and Cats - Lecture | PDF",10]